HomeInsightsPB

Concord Biotech Ltd PB Ratio

Concord Biotech Ltd PB Ratio

stocks purchased

₹ 0.4 Cr

Volume Transacted

(Nov 7, 2024)

stocks purchased

2.1 K

Stocks Traded

(Nov 7, 2024)

Last Updated on: Nov 08, 2024

Image

Concord Biotech Ltd

NSE: CONCORDBIO

PB

12.5

Last updated on: Nov 07, 2024

Key Highlights

  • The P/B Ratio of Concord Biotech Ltd is 12.5 as of 07 Nov 24.
  • The P/B Ratio of Concord Biotech Ltd changed from 10.4 on March 2024 to 10.4 on March 2024 . This represents a CAGR of 0.00% over 1 years. .

Historical P/B Ratio of Concord Biotech Ltd

No data available

Company Fundamentals for Concord Biotech Ltd

Market Cap

19,131 Cr

EPS

29.9

P/E Ratio (TTM) *

61.1

P/B Ratio (TTM) *

12.5

Day’s High *

1873.95

Day’s Low

1822.75

DTE *

0.0

ROE *

20.2

52 Week High

2658.0

52 Week Low

1199.35

ROCE *

27.0

Market Price Over Time

1M

1Y

3Y

5Y

Monitoring Concord Biotech Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
07 Nov 20241828.7
06 Nov 20241838.3
05 Nov 20241812.25
04 Nov 20241812.8
01 Nov 20241857.5
31 Oct 20241836.6
30 Oct 20241807.8
29 Oct 20241818.75
28 Oct 20241828.7
25 Oct 20241805

SWOT Analysis Of Concord Biotech Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Concord Biotech Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Concord Biotech Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/B Ratio

Company NamePBMarket Cap (INR Cr.)
Concord Biotech Ltd1219,131
Sun Pharmaceuticals Industries Ltd984,29,841
Divis Laboratories Ltd5071,58,179
Cipla Ltd3601,27,063
Mankind Pharma Ltd2691,09,234
Dr Reddys Laboratories Ltd3221,07,398

Key Valuation Metric of Concord Biotech Ltd

Share Price

₹1,829

PB Ratio

The price-to-book (P/B) ratio compares a company's market capitalization to its book value by dividing its stock price per share by its book value per share.


How to calculate Price-to-Book (P/B) Ratio?

The Price-to-Book Ratio is used to determine the relationship between the total value of a company's outstanding shares and the net value of its assets. Before calculating the P/B ratio, investors need to overlook the market capitalization of a company.


Market capitalization = market value of a stock X no. of outstanding shares


Now, you need to know the net value of an organization's assets.

Book Value of Assets = Total Assets - Total Liabilities of a company


After knowing the value of the above ratios, here is the formula for the P/B Ratio:

P/B Ratio = Market Capitalization/ Book Value of Assets


or you can also use this formula

P/B ratio = Market Price Per Share/ Book Value of Asset Per Share

Historical Market Cap of Concord Biotech Ltd

No data available

* All values are in crore

Historical Revenue of Concord Biotech Ltd

No data available

* All values are in crore

Historical EBITDA of Concord Biotech Ltd

No data available

* All values are in crore

Historical Net Profit of Concord Biotech Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Concord Biotech Ltd News Hub

News

Concord Biotech to conduct board meeting

Concord Biotech will hold a meeting of the Board of Directors of the Company on 11 Novembe...

Read more

06 Nov 202409:53

News

Volumes jump at Concord Biotech Ltd counter

K E C International Ltd, Sonata Software Ltd, TV18 Broadcast Ltd, ZF Commercial Vehicle Co...

Read more

29 Aug 202414:30

News

Concord Biotech schedules board meeting

Concord Biotech will hold a meeting of the Board of Directors of the Company on 9 August 2...

Read more

31 Jul 202414:25

News

Concord Biotech to conduct AGM

Concord Biotech announced that the 39th Annual General Meeting (AGM) of the company will b...

Read more

31 May 202416:57

News

Volumes spurt at Concord Biotech Ltd counter

Inox Wind Ltd, Sumitomo Chemical India Ltd, Doms Industries Ltd, Natco Pharma Ltd are amon...

Read more

28 May 202414:30

News

Board of Concord Biotech recommends final dividend

Concord Biotech announced that the Board of Directors of the Company at its meeting held o...

Read more

23 May 202419:01

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

Credit Report 2024

dropdown
download

Concalls

FAQs for PB Ratio of Concord Biotech Ltd

What is the PB ratio of Concord Biotech Ltd?

The current PB ratio of Concord Biotech Ltd is 12.53. The Price-to-Book value (P/B) ratio compares a company's current share price to its book value per share. It helps assess whether a stock is overvalued or undervalued relative to its net asset value.

What is the ideal PB ratio to buy Concord Biotech Ltd stocks?

An ideal PB ratio varies by industry; however, a PB ratio below 1.0 may indicate a good buying opportunity for Concord Biotech Ltd. Some investors and financial analysts may also consider any value under 3.0 as a good PB ratio.

How is the PB Ratio of Concord Biotech Ltd calculated?

The PB ratio of Concord Biotech Ltd is calculated by dividing the current share price by the book value per share. The book value per share is determined by dividing the company’s total net assets (assets minus liabilities) by the number of outstanding shares. This ratio helps evaluate how the market values the company's assets.

What does a high PB Ratio mean for Concord Biotech Ltd?

A high PB ratio suggests that Concord Biotech Ltd’s stock may be overvalued relative to its book value or that investors expect high growth.

What does a low PB Ratio indicate for Concord Biotech Ltd?

A low PB ratio of Concord Biotech Ltd may indicate that the stock is undervalued or it is facing financial difficulties.

Can Concord Biotech Ltd PB Ratio change over time?

Yes, the PB ratio of Concord Biotech Ltd can change over time due to fluctuations in the company’s stock price and changes in its book value.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*